Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Autor: Baliakas P, Hadzidimitriou A, Sutton LA, Minga E, Agathangelidis A, Nichelatti M, Tsanousa A, Scarfò L, Davis Z, Yan XJ, Shanafelt T, Plevova K, Sandberg Y, Vojdeman FJ, Boudjogra M, Tzenou T, Chatzouli M, Chu CC, Veronese S, Gardiner A, Mansouri L, Smedby KE, Bredo Pedersen L, van Lom K, Giudicelli V, Skuhrova Francova H, Nguyen Khac F, Panagiotidis P, Juliusson G, Angelis L, Anagnostopoulos A, Lefranc MP, Facco M, Trentin L, Catherwood M, Montillo M, Geisler CH, Langerak AW, Pospisilova S, Chiorazzi N, Oscier D, Jelinek DF, Darzentas N, Belessi C, Davi F, Rosenquist R, GHIA , PAOLO PROSPERO, Stamatopoulos K. Ghia P. is Co senior author, corresponding author

Background About 30% of cases of chronic lymphocytic leukaemia (CLL) carry quasi-identical B-cell receptorimmunoglobulins and can be assigned to distinct stereotyped subsets. Although preliminary evidence suggeststhat B-cell receptor immunoglobulin s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::2595eadcc55666a2f68157db95beda94

Levels of plasma 25-hydroxy vitamin D and risk of developing type 2 diabetes in a large Danish primary health care population.

Autor: Rohold CK; University of Copenhagen, Blegdamsvej 3B, KBH N, 2200, Copenhagen, Denmark., Jørgensen HL; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, KBH N,r, 2200, Copenhagen, Denmark. hlj@dadlnet.dk.; Department of Clinical Biochemistry, Hvidovre Hospital, Kettegård Alle 30, 2650, Hvidovre, Denmark. hlj@dadlnet.dk., Vojdeman FJ; Department of Clinical Biochemistry, Holbæk Hospital, Smedelundsgade 60, 4300, Holbæk, Denmark., Madsen CM; Novo Nordisk A/S, Novo Alle 1, 2880, Bagsværd, Denmark., Olsen A; Danish Cancer Institute, Strandboulevarden 49 KBH Ø, 2100, Copenhagen, Denmark., Heegaard AM; Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 60, KBH Ø, 2100, Copenhagen, Denmark., Lind BS; Department of Clinical Biochemistry, Hvidovre Hospital, Kettegård Alle 30, 2650, Hvidovre, Denmark., Tjønneland A; Danish Cancer Institute, Strandboulevarden 49 KBH Ø, 2100, Copenhagen, Denmark., Schwarz P; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, KBH N,r, 2200, Copenhagen, Denmark.; Department of Endocrinology, Rigshospitalet, Blegdamsvej 9 KBH Ø, 2100, Copenhagen, Denmark., Gæde PH; Department of Endocrinology, Slagelse Hospital, Fælledvej 11, 4200, Slagelse, Denmark.; Faculty of Health Sciences, University of Southern Denmark, Winsløws Parken, J. B. Winsløws Vej 19, 3, 5000, Odense, Denmark.

Publikováno v: Acta diabetologica [Acta Diabetol] 2024 Sep 03. Date of Electronic Publication: 2024 Sep 03.

Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD -genotype variants and P-uracil concentrations.

Autor: Paulsen NH; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.; Clinical Pharmacology, Pharmacy and Environmental Medicine Department of Public Health, University of Southern Denmark, Odense, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Vojdeman FJ; Department of Clinical Biochemistry, Holbaek Hospital, Holbaek, Denmark., Plomgaard P; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Andersen SE; Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark., Ramlov A; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Bertelsen B; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Rossing M; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Nielsen CG; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark., Hoffmann-Lücke E; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.; Institute for Clinical Medicine, Aarhus University of Health, Aarhus, Denmark., Greibe E; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.; Institute for Clinical Medicine, Aarhus University of Health, Aarhus, Denmark., Spangsberg Holm H; Department of Oncology, Odense University Hospital, Odense, Denmark., Nielsen HH; Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark., Lolas IBY; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark., Madsen JS; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark., Bergmann ML; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark., Mørk M; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark., Fruekilde PBN; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark., Bøttger P; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark., Petersen PC; Department of Oncology, Zealand University Hospital, Roskilde, Denmark., Nissen PH; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.; Denmark and Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark., Feddersen S; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Bergmann TK; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.; Department of Regional Health Research, University of Southern Denmark, Esbjerg, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Damkier P; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.; Clinical Pharmacology, Pharmacy and Environmental Medicine Department of Public Health, University of Southern Denmark, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Nov; Vol. 61 (11), pp. 1400-1405. Date of Electronic Publication: 2022 Oct 18.

Chronic lymphocytic leukaemia clones are detectable decades before diagnosis.

Autor: Vojdeman FJ; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark., Helby J; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Herlev, Denmark.; The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Herlev, Denmark., Pedersen LB; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Herlev, Denmark., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Herlev, Denmark., Andersen MA; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Herlev, Denmark., Nordestgaard BG; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Herlev, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Herlev, Denmark., Bojesen SE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Herlev, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Herlev, Denmark., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Herlev, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Herlev, Denmark.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. 784-787. Date of Electronic Publication: 2021 Sep 27.

[The Danish screening programme for haemoglobinopathies].

Autor: Glenthøj A; andreas.glenthoej@regionh.dk., Samson M, Toft N, Diness BR, Askj R N, Vojdeman FJ, Birgens H, Sørensen MB, Petersen J

Publikováno v: Ugeskrift for laeger [Ugeskr Laeger] 2021 Jan 18; Vol. 183 (3).